John P. Butler, Director at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 53 shares at $1.01 ($54) on 2022-06-14, disclosed to the SEC on 2022-06-16.
Open-market sale of $54 ZYNE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |